BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1528 related articles for article (PubMed ID: 19197972)

  • 1. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
    Mirabello L; Troisi RJ; Savage SA
    Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.
    Cole S; Gianferante DM; Zhu B; Mirabello L
    Cancer; 2022 Jun; 128(11):2107-2118. PubMed ID: 35226758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
    Wu J; Sun H; Li J; Guo Y; Zhang K; Lang C; Zou C; Ma H
    Cancer Med; 2018 Aug; 7(8):3652-3661. PubMed ID: 29992762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma as a second malignant neoplasm.
    Hamre MR; Severson RK; Chuba P; Lucas DR; Thomas RL; Mott MP
    Radiother Oncol; 2002 Dec; 65(3):153-7. PubMed ID: 12464443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of osteosarcoma.
    Ottaviani G; Jaffe N
    Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
    Duong LM; Richardson LC
    J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
    Jawad MU; Bayne CO; Farhan S; Haffner MR; Carr-Ascher J; Alvarez E; Thorpe SW; Randall RL
    J Surg Oncol; 2021 Dec; 124(8):1515-1522. PubMed ID: 34432316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric head and neck bone sarcomas: An analysis of 204 cases.
    Brady JS; Chung SY; Marchiano E; Eloy JA; Baredes S; Park RCW
    Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():71-76. PubMed ID: 28802390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
    Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS
    Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
    Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
    Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
    J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing prognostic factors in osteosarcoma: analysis of 381 cases from two institutions.
    Xing D; Qasem SA; Owusu K; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2014 Aug; 45(8):1688-96. PubMed ID: 24931466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.
    Mirabello L; Troisi RJ; Savage SA
    Int J Cancer; 2009 Jul; 125(1):229-34. PubMed ID: 19330840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Primary Malignancies of the Bones and Joints: More Common than Expected in Osteosarcoma Patients.
    Freedman IG; Dowd HN; Dhodapkar MM; Halperin SJ; Grauer JN
    J Am Acad Orthop Surg Glob Res Rev; 2023 Jan; 7(1):. PubMed ID: 36695170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and survival rates of children and young adults with osteogenic sarcoma.
    Homa DM; Sowers MR; Schwartz AG
    Cancer; 1991 Apr; 67(8):2219-23. PubMed ID: 2004344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
    Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
    Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma in New Zealand 1981-7: an overview.
    Mills HJ; Horne G; Devane P
    N Z Med J; 1995 Nov; 108(1011):458-9. PubMed ID: 8538963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.